Pinealon (Glu-Asp-Arg) is a research bioregulatory tripeptide developed to target the central nervous system, studied for its neuroprotective effects, and its impact on memory and overall brain functions.
Composition
5 mg per vial
Experimental Exposure (Research)
Research Exposure: 100–300 mcg
Studied for its neuroprotective effects
For use exclusively in a controlled research environment
Informational Benefits (Research)
Studies on memory enhancement
Research on cellular neuroprotection
Exploration of oxidative stress resistance
Analysis of global cognitive support
Studies on neuronal longevity
Potential support for brain functions
For research use only - Not for human consumption.
